カテゴリー： LP Information, 世界, 部品/材料

世界の心血管・脳血管API市場予測 2021年-2026年

【英語タイトル】Global Cardiovascular and Cerebrovascular API Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY0941）・商品コード：LPI21MY0941
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：167
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：化学＆材料
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「心血管・脳血管APIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、サルタン心血管・脳血管API、スタチン心血管・脳血管API、プリ心血管・脳血管APIなど、用途別には、経口薬、注射薬などにセグメント区分してまとめました。心血管・脳血管APIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・心血管・脳血管APIの世界市場概要（サマリー）
・心血管・脳血管APIの企業別販売量・売上
・心血管・脳血管APIの企業別市場シェア
・心血管・脳血管APIの世界市場規模 2016年-2021年：種類別（サルタン心血管・脳血管API、スタチン心血管・脳血管API、プリ心血管・脳血管API）
・心血管・脳血管APIの世界市場規模 2016年-2021年：用途別（経口薬、注射薬）
・心血管・脳血管APIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・心血管・脳血管APIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・心血管・脳血管APIのヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・心血管・脳血管APIの中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・心血管・脳血管API市場の成長要因・課題・動向
・心血管・脳血管APIの世界市場予測 2021年-2026年
・心血管・脳血管APIの南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・心血管・脳血管APIのアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・心血管・脳血管APIのヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・心血管・脳血管APIの中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・心血管・脳血管APIの世界市場予測：種類別（サルタン心血管・脳血管API、スタチン心血管・脳血管API、プリ心血管・脳血管API）
・心血管・脳血管APIの世界市場予測：用途別（経口薬、注射薬）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of Cardiovascular and Cerebrovascular API will have significant change from previous year. By the most conservative estimates of global Cardiovascular and Cerebrovascular API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 2941.1 million in 2020. Over the next five years the Cardiovascular and Cerebrovascular API market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 3282 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular and Cerebrovascular API market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Sartans Cardiovascular and Cerebrovascular API
Statins Cardiovascular and Cerebrovascular API
Puri Cardiovascular and Cerebrovascular API

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Oral Drugs
Injection Drugs

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Zhuhai Rundu Pharmaceutical
Ningbo Menovo Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Tianyu Pharmaceutical
Zhejiang Hisun Pharmaceutical
Zhejiang Lepu Pharmaceutical
Zhejiang Jiangbei Pharmaceutical
DR.Reddy
Glenmerk
Cipla
MSN Life Sciences

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiovascular and Cerebrovascular API Consumption 2016-2026
2.1.2 Cardiovascular and Cerebrovascular API Consumption CAGR by Region
2.2 Cardiovascular and Cerebrovascular API Segment by Type
2.2.1 Sartans Cardiovascular and Cerebrovascular API
2.2.2 Statins Cardiovascular and Cerebrovascular API
2.2.3 Puri Cardiovascular and Cerebrovascular API
2.3 Cardiovascular and Cerebrovascular API Sales by Type
2.3.1 Global Cardiovascular and Cerebrovascular API Sales Market Share by Type (2016-2021)
2.3.2 Global Cardiovascular and Cerebrovascular API Revenue and Market Share by Type (2016-2021)
2.3.3 Global Cardiovascular and Cerebrovascular API Sale Price by Type (2016-2021)
2.4 Cardiovascular and Cerebrovascular API Segment by Application
2.4.1 Oral Drugs
2.4.2 Injection Drugs
2.5 Cardiovascular and Cerebrovascular API Sales by Application
2.5.1 Global Cardiovascular and Cerebrovascular API Sale Market Share by Application (2016-2021)
2.5.2 Global Cardiovascular and Cerebrovascular API Revenue and Market Share by Application (2016-2021)
2.5.3 Global Cardiovascular and Cerebrovascular API Sale Price by Application (2016-2021)

3 Global Cardiovascular and Cerebrovascular API by Company
3.1 Global Cardiovascular and Cerebrovascular API Sales Market Share by Company
3.1.1 Global Cardiovascular and Cerebrovascular API Sales by Company (2019-2021)
3.1.2 Global Cardiovascular and Cerebrovascular API Sales Market Share by Company (2019-2021)
3.2 Global Cardiovascular and Cerebrovascular API Revenue Market Share by Company
3.2.1 Global Cardiovascular and Cerebrovascular API Revenue by Company (2019-2021)
3.2.2 Global Cardiovascular and Cerebrovascular API Revenue Market Share by Company (2019-2021)
3.3 Global Cardiovascular and Cerebrovascular API Sale Price by Company
3.4 Global Manufacturers Cardiovascular and Cerebrovascular API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cardiovascular and Cerebrovascular API Product Location Distribution
3.4.2 Players Cardiovascular and Cerebrovascular API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Cardiovascular and Cerebrovascular API by Region
4.1 Global Cardiovascular and Cerebrovascular API by Region
4.1.1 Global Cardiovascular and Cerebrovascular API Sales by Region
4.1.2 Global Cardiovascular and Cerebrovascular API Revenue by Region
4.2 Americas Cardiovascular and Cerebrovascular API Sales Growth
4.3 APAC Cardiovascular and Cerebrovascular API Sales Growth
4.4 Europe Cardiovascular and Cerebrovascular API Sales Growth
4.5 Middle East & Africa Cardiovascular and Cerebrovascular API Sales Growth

5 Americas
5.1 Americas Cardiovascular and Cerebrovascular API Sales by Country
5.1.1 Americas Cardiovascular and Cerebrovascular API Sales by Country (2016-2021)
5.1.2 Americas Cardiovascular and Cerebrovascular API Revenue by Country (2016-2021)
5.2 Americas Cardiovascular and Cerebrovascular API Sales by Type
5.3 Americas Cardiovascular and Cerebrovascular API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cardiovascular and Cerebrovascular API Sales by Region
6.1.1 APAC Cardiovascular and Cerebrovascular API Sales by Region (2016-2021)
6.1.2 APAC Cardiovascular and Cerebrovascular API Revenue by Region (2016-2021)
6.2 APAC Cardiovascular and Cerebrovascular API Sales by Type
6.3 APAC Cardiovascular and Cerebrovascular API Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cardiovascular and Cerebrovascular API by Country
7.1.1 Europe Cardiovascular and Cerebrovascular API Sales by Country (2016-2021)
7.1.2 Europe Cardiovascular and Cerebrovascular API Revenue by Country (2016-2021)
7.2 Europe Cardiovascular and Cerebrovascular API Sales by Type
7.3 Europe Cardiovascular and Cerebrovascular API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cardiovascular and Cerebrovascular API by Country
8.1.1 Middle East & Africa Cardiovascular and Cerebrovascular API Sales by Country (2016-2021)
8.1.2 Middle East & Africa Cardiovascular and Cerebrovascular API Revenue by Country (2016-2021)
8.2 Middle East & Africa Cardiovascular and Cerebrovascular API Sales by Type
8.3 Middle East & Africa Cardiovascular and Cerebrovascular API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cardiovascular and Cerebrovascular API Distributors
10.3 Cardiovascular and Cerebrovascular API Customer

11 Global Cardiovascular and Cerebrovascular API Market Forecast
11.1 Global Cardiovascular and Cerebrovascular API Forecast by Region
11.1.1 Global Cardiovascular and Cerebrovascular API Forecast by Regions (2021-2026)
11.2.2 Global Cardiovascular and Cerebrovascular API Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Cardiovascular and Cerebrovascular API Forecast by Type
11.7 Global Cardiovascular and Cerebrovascular API Forecast by Application

12 Key Players Analysis
12.1 Zhuhai Rundu Pharmaceutical
12.1.1 Zhuhai Rundu Pharmaceutical Company Information
12.1.2 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
12.1.3 Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Zhuhai Rundu Pharmaceutical Main Business Overview
12.1.5 Zhuhai Rundu Pharmaceutical Latest Developments
12.2 Ningbo Menovo Pharmaceutical
12.2.1 Ningbo Menovo Pharmaceutical Company Information
12.2.2 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
12.2.3 Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Ningbo Menovo Pharmaceutical Main Business Overview
12.2.5 Ningbo Menovo Pharmaceutical Latest Developments
12.3 Zhejiang Huahai Pharmaceutical
12.3.1 Zhejiang Huahai Pharmaceutical Company Information
12.3.2 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
12.3.3 Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Zhejiang Huahai Pharmaceutical Main Business Overview
12.3.5 Zhejiang Huahai Pharmaceutical Latest Developments
12.4 Zhejiang Tianyu Pharmaceutical
12.4.1 Zhejiang Tianyu Pharmaceutical Company Information
12.4.2 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
12.4.3 Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Zhejiang Tianyu Pharmaceutical Main Business Overview
12.4.5 Zhejiang Tianyu Pharmaceutical Latest Developments
12.5 Zhejiang Hisun Pharmaceutical
12.5.1 Zhejiang Hisun Pharmaceutical Company Information
12.5.2 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
12.5.3 Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Zhejiang Hisun Pharmaceutical Main Business Overview
12.5.5 Zhejiang Hisun Pharmaceutical Latest Developments
12.6 Zhejiang Lepu Pharmaceutical
12.6.1 Zhejiang Lepu Pharmaceutical Company Information
12.6.2 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
12.6.3 Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Zhejiang Lepu Pharmaceutical Main Business Overview
12.6.5 Zhejiang Lepu Pharmaceutical Latest Developments
12.7 Zhejiang Jiangbei Pharmaceutical
12.7.1 Zhejiang Jiangbei Pharmaceutical Company Information
12.7.2 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
12.7.3 Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Zhejiang Jiangbei Pharmaceutical Main Business Overview
12.7.5 Zhejiang Jiangbei Pharmaceutical Latest Developments
12.8 DR.Reddy
12.8.1 DR.Reddy Company Information
12.8.2 DR.Reddy Cardiovascular and Cerebrovascular API Product Offered
12.8.3 DR.Reddy Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 DR.Reddy Main Business Overview
12.8.5 DR.Reddy Latest Developments
12.9 Glenmerk
12.9.1 Glenmerk Company Information
12.9.2 Glenmerk Cardiovascular and Cerebrovascular API Product Offered
12.9.3 Glenmerk Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Glenmerk Main Business Overview
12.9.5 Glenmerk Latest Developments
12.10 Cipla
12.10.1 Cipla Company Information
12.10.2 Cipla Cardiovascular and Cerebrovascular API Product Offered
12.10.3 Cipla Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Cipla Main Business Overview
12.10.5 Cipla Latest Developments
12.11 MSN Life Sciences
12.11.1 MSN Life Sciences Company Information
12.11.2 MSN Life Sciences Cardiovascular and Cerebrovascular API Product Offered
12.11.3 MSN Life Sciences Cardiovascular and Cerebrovascular API Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 MSN Life Sciences Main Business Overview
12.11.5 MSN Life Sciences Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Cardiovascular and Cerebrovascular API Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Sartans Cardiovascular and Cerebrovascular API
Table 3. Major Players of Statins Cardiovascular and Cerebrovascular API
Table 4. Major Players of Puri Cardiovascular and Cerebrovascular API
Table 5. Global Cardiovascular and Cerebrovascular API Sales by Type (2016-2021) & (MT)
Table 6. Global Cardiovascular and Cerebrovascular API Sales Market Share by Type (2016-2021)
Table 7. Global Cardiovascular and Cerebrovascular API Revenue by Type (2016-2021) & ($ million)
Table 8. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Type (2016-2021)
Table 9. Global Cardiovascular and Cerebrovascular API Sale Price by Type (2016-2021)
Table 10. Global Cardiovascular and Cerebrovascular API Sales by Application (2016-2021) & (MT)
Table 11. Global Cardiovascular and Cerebrovascular API Sales Market Share by Application (2016-2021)
Table 12. Global Cardiovascular and Cerebrovascular API Value by Application (2016-2021)
Table 13. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Application (2016-2021)
Table 14. Global Cardiovascular and Cerebrovascular API Sale Price by Application (2016-2021)
Table 15. Global Cardiovascular and Cerebrovascular API Sales by Company (2019-2021) & (MT)
Table 16. Global Cardiovascular and Cerebrovascular API Sales Market Share by Company (2019-2021)
Table 17. Global Cardiovascular and Cerebrovascular API Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Company (2019-2021)
Table 19. Global Cardiovascular and Cerebrovascular API Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Cardiovascular and Cerebrovascular API Producing Area Distribution and Sales Area
Table 21. Players Cardiovascular and Cerebrovascular API Products Offered
Table 22. Cardiovascular and Cerebrovascular API Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Cardiovascular and Cerebrovascular API Sales by Region (2016-2021) (MT)
Table 26. Global Cardiovascular and Cerebrovascular API Sales Market Share by Region (2016-2021)
Table 27. Global Cardiovascular and Cerebrovascular API Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Region (2016-2021)
Table 29. Americas Cardiovascular and Cerebrovascular API Sales by Country (2016-2021) & (MT)
Table 30. Americas Cardiovascular and Cerebrovascular API Sales Market Share by Country (2016-2021)
Table 31. Americas Cardiovascular and Cerebrovascular API Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Cardiovascular and Cerebrovascular API Revenue Market Share by Country (2016-2021)
Table 33. Americas Cardiovascular and Cerebrovascular API Sales by Type (2016-2021) & (MT)
Table 34. Americas Cardiovascular and Cerebrovascular API Sales Market Share by Type (2016-2021)
Table 35. Americas Cardiovascular and Cerebrovascular API Sales by Application (2016-2021) & (MT)
Table 36. Americas Cardiovascular and Cerebrovascular API Sales Market Share by Application (2016-2021)
Table 37. APAC Cardiovascular and Cerebrovascular API Sales by Region (2016-2021) & (MT)
Table 38. APAC Cardiovascular and Cerebrovascular API Sales Market Share by Region (2016-2021)
Table 39. APAC Cardiovascular and Cerebrovascular API Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Cardiovascular and Cerebrovascular API Revenue Market Share by Region (2016-2021)
Table 41. APAC Cardiovascular and Cerebrovascular API Sales by Type (2016-2021) & (MT)
Table 42. APAC Cardiovascular and Cerebrovascular API Sales Market Share by Type (2016-2021)
Table 43. APAC Cardiovascular and Cerebrovascular API Sales by Application (2016-2021) & (MT)
Table 44. APAC Cardiovascular and Cerebrovascular API Sales Market Share by Application (2016-2021)
Table 45. Europe Cardiovascular and Cerebrovascular API Sales by Country (2016-2021) & (MT)
Table 46. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Country (2016-2021)
Table 47. Europe Cardiovascular and Cerebrovascular API Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Cardiovascular and Cerebrovascular API Revenue Market Share by Country (2016-2021)
Table 49. Europe Cardiovascular and Cerebrovascular API Sales by Type (2016-2021) & (MT)
Table 50. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Type (2016-2021)
Table 51. Europe Cardiovascular and Cerebrovascular API Sales by Application (2016-2021) & (MT)
Table 52. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Cardiovascular and Cerebrovascular API Sales by Country (2016-2021) & (MT)
Table 54. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Cardiovascular and Cerebrovascular API Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Cardiovascular and Cerebrovascular API Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Cardiovascular and Cerebrovascular API Sales by Type (2016-2021) & (MT)
Table 58. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Cardiovascular and Cerebrovascular API Sales by Application (2016-2021) & (MT)
Table 60. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Cardiovascular and Cerebrovascular API
Table 62. Key Application and Potential Industries of Cardiovascular and Cerebrovascular API
Table 63. Key Challenges of Cardiovascular and Cerebrovascular API
Table 64. Key Trends of Cardiovascular and Cerebrovascular API
Table 65. Cardiovascular and Cerebrovascular API Distributors List
Table 66. Cardiovascular and Cerebrovascular API Customer List
Table 67. Global Cardiovascular and Cerebrovascular API Sales Forecast by Region (2021-2026) & (MT)
Table 68. Global Cardiovascular and Cerebrovascular API Consumption Market Forecast by Region
Table 69. Global Cardiovascular and Cerebrovascular API Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Cardiovascular and Cerebrovascular API Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Cardiovascular and Cerebrovascular API Sales Forecast by Country (2021-2026) & (MT)
Table 72. Americas Cardiovascular and Cerebrovascular API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Cardiovascular and Cerebrovascular API Sales Forecast by Region (2021-2026) & (MT)
Table 74. APAC Cardiovascular and Cerebrovascular API Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Cardiovascular and Cerebrovascular API Sales Forecast by Country (2021-2026) & (MT)
Table 76. Europe Cardiovascular and Cerebrovascular API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Forecast by Country (2021-2026) & (MT)
Table 78. Middle East & Africa Cardiovascular and Cerebrovascular API Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Cardiovascular and Cerebrovascular API Sales Forecast by Type (2021-2026) & (MT)
Table 80. Global Cardiovascular and Cerebrovascular API Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Cardiovascular and Cerebrovascular API Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Cardiovascular and Cerebrovascular API Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Cardiovascular and Cerebrovascular API Sales Forecast by Application (2021-2026) & (MT)
Table 84. Global Cardiovascular and Cerebrovascular API Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Cardiovascular and Cerebrovascular API Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Cardiovascular and Cerebrovascular API Revenue Market Share Forecast by Application (2021-2026)
Table 87. Zhuhai Rundu Pharmaceutical Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 88. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
Table 89. Zhuhai Rundu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 90. Zhuhai Rundu Pharmaceutical Main Business
Table 91. Zhuhai Rundu Pharmaceutical Latest Developments
Table 92. Ningbo Menovo Pharmaceutical Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 93. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
Table 94. Ningbo Menovo Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 95. Ningbo Menovo Pharmaceutical Main Business
Table 96. Ningbo Menovo Pharmaceutical Latest Developments
Table 97. Zhejiang Huahai Pharmaceutical Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 98. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
Table 99. Zhejiang Huahai Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 100. Zhejiang Huahai Pharmaceutical Main Business
Table 101. Zhejiang Huahai Pharmaceutical Latest Developments
Table 102. Zhejiang Tianyu Pharmaceutical Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 103. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
Table 104. Zhejiang Tianyu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 105. Zhejiang Tianyu Pharmaceutical Main Business
Table 106. Zhejiang Tianyu Pharmaceutical Latest Developments
Table 107. Zhejiang Hisun Pharmaceutical Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 108. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
Table 109. Zhejiang Hisun Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 110. Zhejiang Hisun Pharmaceutical Main Business
Table 111. Zhejiang Hisun Pharmaceutical Latest Developments
Table 112. Zhejiang Lepu Pharmaceutical Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
Table 114. Zhejiang Lepu Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 115. Zhejiang Lepu Pharmaceutical Main Business
Table 116. Zhejiang Lepu Pharmaceutical Latest Developments
Table 117. Zhejiang Jiangbei Pharmaceutical Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Product Offered
Table 119. Zhejiang Jiangbei Pharmaceutical Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 120. Zhejiang Jiangbei Pharmaceutical Main Business
Table 121. Zhejiang Jiangbei Pharmaceutical Latest Developments
Table 122. DR.Reddy Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 123. DR.Reddy Cardiovascular and Cerebrovascular API Product Offered
Table 124. DR.Reddy Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 125. DR.Reddy Main Business
Table 126. DR.Reddy Latest Developments
Table 127. Glenmerk Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 128. Glenmerk Cardiovascular and Cerebrovascular API Product Offered
Table 129. Glenmerk Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 130. Glenmerk Main Business
Table 131. Glenmerk Latest Developments
Table 132. Cipla Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 133. Cipla Cardiovascular and Cerebrovascular API Product Offered
Table 134. Cipla Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 135. Cipla Main Business
Table 136. Cipla Latest Developments
Table 137. MSN Life Sciences Basic Information, Cardiovascular and Cerebrovascular API Manufacturing Base, Sales Area and Its Competitors
Table 138. MSN Life Sciences Cardiovascular and Cerebrovascular API Product Offered
Table 139. MSN Life Sciences Cardiovascular and Cerebrovascular API Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2019-2021E)
Table 140. MSN Life Sciences Main Business
Table 141. MSN Life Sciences Latest Developments
List of Figures
Figure 1. Picture of Cardiovascular and Cerebrovascular API
Figure 2. Cardiovascular and Cerebrovascular API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cardiovascular and Cerebrovascular API Sales Growth Rate 2016-2026 (MT)
Figure 7. Global Cardiovascular and Cerebrovascular API Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Cardiovascular and Cerebrovascular API Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Sartans Cardiovascular and Cerebrovascular API
Figure 10. Product Picture of Statins Cardiovascular and Cerebrovascular API
Figure 11. Product Picture of Puri Cardiovascular and Cerebrovascular API
Figure 12. Global Cardiovascular and Cerebrovascular API Sales Market Share by Type in 2020
Figure 13. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Type (2016-2021)
Figure 14. Cardiovascular and Cerebrovascular API Consumed in Oral Drugs
Figure 15. Global Cardiovascular and Cerebrovascular API Market: Oral Drugs (2016-2021) & (MT)
Figure 16. Cardiovascular and Cerebrovascular API Consumed in Injection Drugs
Figure 17. Global Cardiovascular and Cerebrovascular API Market: Injection Drugs (2016-2021) & (MT)
Figure 18. Global Cardiovascular and Cerebrovascular API Sales Market Share by Application (2016-2021)
Figure 19. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Application in 2020
Figure 20. Cardiovascular and Cerebrovascular API Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Company in 2020
Figure 22. Global Cardiovascular and Cerebrovascular API Sales Market Share by Regions (2016-2021)
Figure 23. Global Cardiovascular and Cerebrovascular API Revenue Market Share by Region in 2020
Figure 24. Americas Cardiovascular and Cerebrovascular API Sales 2016-2021 (MT)
Figure 25. Americas Cardiovascular and Cerebrovascular API Revenue 2016-2021 ($ Millions)
Figure 26. APAC Cardiovascular and Cerebrovascular API Sales 2016-2021 (MT)
Figure 27. APAC Cardiovascular and Cerebrovascular API Revenue 2016-2021 ($ Millions)
Figure 28. Europe Cardiovascular and Cerebrovascular API Sales 2016-2021 (MT)
Figure 29. Europe Cardiovascular and Cerebrovascular API Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Cardiovascular and Cerebrovascular API Sales 2016-2021 (MT)
Figure 31. Middle East & Africa Cardiovascular and Cerebrovascular API Revenue 2016-2021 ($ Millions)
Figure 32. Americas Cardiovascular and Cerebrovascular API Sales Market Share by Country in 2020
Figure 33. Americas Cardiovascular and Cerebrovascular API Revenue Market Share by Country in 2020
Figure 34. Americas Cardiovascular and Cerebrovascular API Sales Market Share by Type in 2020
Figure 35. Americas Cardiovascular and Cerebrovascular API Sales Market Share by Application in 2020
Figure 36. United States Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Cardiovascular and Cerebrovascular API Sales Market Share by Region in 2020
Figure 41. APAC Cardiovascular and Cerebrovascular API Revenue Market Share by Regions in 2020
Figure 42. APAC Cardiovascular and Cerebrovascular API Sales Market Share by Type in 2020
Figure 43. APAC Cardiovascular and Cerebrovascular API Sales Market Share by Application in 2020
Figure 44. China Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Country in 2020
Figure 51. Europe Cardiovascular and Cerebrovascular API Revenue Market Share by Country in 2020
Figure 52. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Type in 2020
Figure 53. Europe Cardiovascular and Cerebrovascular API Sales Market Share by Application in 2020
Figure 54. Germany Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Cardiovascular and Cerebrovascular API Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Cardiovascular and Cerebrovascular API Sales Market Share by Application in 2020
Figure 63. Egypt Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Cardiovascular and Cerebrovascular API Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


★調査レポート[世界の心血管・脳血管API市場予測 2021年-2026年] (コード：LPI21MY0941)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の心血管・脳血管API市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の心血管疾患治療薬市場予測 2021年-2026年
    LPI21MY9466 / LP Information / 2021年5月 / LPインフォメーション社の「心血管疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他など、用途別には、虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他などにセグメント区分してまとめました。心血管疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管疾患治療薬の世界市場概要（サマリー） ・心血管疾患治療薬の企業別販売量・売上 ・心血管疾患治療薬の企業別市場シェア ・心血管疾患治療薬の世界市場規模 2016年-2021年：種類別（ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他） ・心血管疾患治療薬の世界市場規模 2016年-2021年：用途別（虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他） ・心血管疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Disease Drugs will have significant change from previous year. By the most conservative estimates of global Cardiovascular Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cardiovascular Disease Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Disease Drugs market by product type,...
  • 世界の心血管手術用装置・技術市場予測 2021年-2026年
    LPI21MY8809 / LP Information / 2021年5月 / LPインフォメーション社の「心血管手術用装置・技術の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、鼓動用心臓手術システム、灌流使い捨て品、CPB機器、心臓アブレーション装置など、用途別には、医療機器製造会社、研究所、製薬会社、学術・医療機関などにセグメント区分してまとめました。心血管手術用装置・技術のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管手術用装置・技術の世界市場概要（サマリー） ・心血管手術用装置・技術の企業別販売量・売上 ・心血管手術用装置・技術の企業別市場シェア ・心血管手術用装置・技術の世界市場規模 2016年-2021年：種類別（鼓動用心臓手術システム、灌流使い捨て品、CPB機器、心臓アブレーション装置） ・心血管手術用装置・技術の世界市場規模 2016年-2021年：用途別（医療機器製造会社、研究所、製薬会社、学術・医療機関） ・心血管手術用装置・技術の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管手術用装置・技術のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Surgical Devices and Technologies will have significant change from previous year. By the most conservative estimates of global Cardiovascular Surgical Devices and Technologies market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1369 million in 2019. Over the next five years the Cardiovascular Surgical Devices and Technologies market will register a 3.9% CAGR in terms of revenue, the global market size will reach US$ 1594.3 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular...
  • 世界のイオヘキソール市場予測 2021年-2026年
    LPI21MY2604 / LP Information / 2021年5月 / LPインフォメーション社の「イオヘキソールの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、0.99、0.98、その他など、用途別には、造影剤、診断剤、その他などにセグメント区分してまとめました。イオヘキソールのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・イオヘキソールの世界市場概要（サマリー） ・イオヘキソールの企業別販売量・売上 ・イオヘキソールの企業別市場シェア ・イオヘキソールの世界市場規模 2016年-2021年：種類別（0.99、0.98、その他） ・イオヘキソールの世界市場規模 2016年-2021年：用途別（造影剤、診断剤、その他） ・イオヘキソールの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・イオヘキソールのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Iohexol (CAS 66108-95-0) will have significant change from previous year. By the most conservative estimates of global Iohexol (CAS 66108-95-0) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Iohexol (CAS 66108-95-0) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Iohexol (CAS 66108-95-0) market by product type,...
  • 世界の心血管手術用装置市場予測 2021年-2026年
    LPI21MY8808 / LP Information / 2021年5月 / LPインフォメーション社の「心血管手術用装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、灌流用使い捨て品、心肺バイパス装置、鼓動心臓手術治療、補助人工心臓、心臓アブレーション装置、その他など、用途別には、介入心臓手術、心臓リズム管理、従来型心臓手術、その他などにセグメント区分してまとめました。心血管手術用装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管手術用装置の世界市場概要（サマリー） ・心血管手術用装置の企業別販売量・売上 ・心血管手術用装置の企業別市場シェア ・心血管手術用装置の世界市場規模 2016年-2021年：種類別（灌流用使い捨て品、心肺バイパス装置、鼓動心臓手術治療、補助人工心臓、心臓アブレーション装置、その他） ・心血管手術用装置の世界市場規模 2016年-2021年：用途別（介入心臓手術、心臓リズム管理、従来型心臓手術、その他） ・心血管手術用装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管手術用装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Surgical Devices will have significant change from previous year. By the most conservative estimates of global Cardiovascular Surgical Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 42150 million in 2019. Over the next five years the Cardiovascular Surgical Devices market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 52270 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Surgical Devices market by product type,...
  • 世界の心血管補綴装置市場予測 2021年-2026年
    LPI21MY8807 / LP Information / 2021年5月 / LPインフォメーション社の「心血管補綴装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、心臓補綴装置、血管補綴装置など、用途別には、手術、研究などにセグメント区分してまとめました。心血管補綴装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管補綴装置の世界市場概要（サマリー） ・心血管補綴装置の企業別販売量・売上 ・心血管補綴装置の企業別市場シェア ・心血管補綴装置の世界市場規模 2016年-2021年：種類別（心臓補綴装置、血管補綴装置） ・心血管補綴装置の世界市場規模 2016年-2021年：用途別（手術、研究） ・心血管補綴装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管補綴装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Prosthetic Devices will have significant change from previous year. By the most conservative estimates of global Cardiovascular Prosthetic Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 34840 million in 2019. Over the next five years the Cardiovascular Prosthetic Devices market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 40760 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Prosthetic Devices market by product type,...
  • 世界の心血管超音波市場予測 2021年-2026年
    LPI21MY8810 / LP Information / 2021年5月 / LPインフォメーション社の「心血管超音波の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、経胸壁心エコー図、経食道心エコー図、ストレス心エコー図、その他心エコー図など、用途別には、病院、循環器センター、外来、在宅医療、外来センター、その他などにセグメント区分してまとめました。心血管超音波のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管超音波の世界市場概要（サマリー） ・心血管超音波の企業別販売量・売上 ・心血管超音波の企業別市場シェア ・心血管超音波の世界市場規模 2016年-2021年：種類別（経胸壁心エコー図、経食道心エコー図、ストレス心エコー図、その他心エコー図） ・心血管超音波の世界市場規模 2016年-2021年：用途別（病院、循環器センター、外来、在宅医療、外来センター、その他） ・心血管超音波の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管超音波のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Ultrasound will have significant change from previous year. By the most conservative estimates of global Cardiovascular Ultrasound market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1099.9 million in 2019. Over the next five years the Cardiovascular Ultrasound market will register a 5.3% CAGR in terms of revenue, the global market size will reach US$ 1352 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Ultrasound market by product type, application, key manufacturers and...
  • 世界のカルバペネムAPI市場予測 2021年-2026年
    LPI21MY0916 / LP Information / 2021年5月 / LPインフォメーション社の「カルバペネムAPIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、エルタペネムAPI、イミペネムAPI、メロペネムAPI、その他など、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。カルバペネムAPIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・カルバペネムAPIの世界市場概要（サマリー） ・カルバペネムAPIの企業別販売量・売上 ・カルバペネムAPIの企業別市場シェア ・カルバペネムAPIの世界市場規模 2016年-2021年：種類別（エルタペネムAPI、イミペネムAPI、メロペネムAPI、その他） ・カルバペネムAPIの世界市場規模 2016年-2021年：用途別（静脈注射、筋肉内注射） ・カルバペネムAPIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・カルバペネムAPIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Carbapenem API will have significant change from previous year. By the most conservative estimates of global Carbapenem API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Carbapenem API market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Carbapenem API market by product type, application, key manufacturers and...
  • 世界のメロペネムAPI市場予測 2021年-2026年
    LPI21MY1887 / LP Information / 2021年5月 / LPインフォメーション社の「メロペネムAPIの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、粗メロペネム、注射グレードメロペネムなど、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。メロペネムAPIのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・メロペネムAPIの世界市場概要（サマリー） ・メロペネムAPIの企業別販売量・売上 ・メロペネムAPIの企業別市場シェア ・メロペネムAPIの世界市場規模 2016年-2021年：種類別（粗メロペネム、注射グレードメロペネム） ・メロペネムAPIの世界市場規模 2016年-2021年：用途別（静脈注射、筋肉内注射） ・メロペネムAPIの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・メロペネムAPIのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Meropenem API will have significant change from previous year. By the most conservative estimates of global Meropenem API market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the Meropenem API market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Meropenem API market by product type, application, key manufacturers and...
  • 世界の注射用エルタペネム市場予測 2021年-2026年
    LPI21MY1305 / LP Information / 2021年5月 / LPインフォメーション社の「注射用エルタペネムの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度> 98％、純度> 99％など、用途別には、静脈注射、筋肉内注射などにセグメント区分してまとめました。注射用エルタペネムのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・注射用エルタペネムの世界市場概要（サマリー） ・注射用エルタペネムの企業別販売量・売上 ・注射用エルタペネムの企業別市場シェア ・注射用エルタペネムの世界市場規模 2016年-2021年：種類別（純度> 98％、純度> 99％）...According to this latest study, the 2021 growth of Ertapenem for Injection will have significant change from previous year. By the most conservative estimates of global Ertapenem for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Ertapenem for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Ertapenem for Injection market by product type,...
  • 世界のパラセタモール有効成分市場予測 2021年-2026年
    LPI21MY2144 / LP Information / 2021年5月 / LPインフォメーション社の「パラセタモール有効成分の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）など、用途別には、頭痛＆発熱、風邪＆咳、筋肉けいれん、その他などにセグメント区分してまとめました。パラセタモール有効成分のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・パラセタモール有効成分の世界市場概要（サマリー） ・パラセタモール有効成分の企業別販売量・売上 ・パラセタモール有効成分の企業別市場シェア ・パラセタモール有効成分の世界市場規模 2016年-2021年：種類別（純度（99％-99.5％）、純度（99.5％以上）、純度（99％以下）） ・パラセタモール有効成分の世界市場規模 2016年-2021年：用途別（頭痛＆発熱、風邪＆咳、筋肉けいれん、その他） ・パラセタモール有効成分の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・パラセタモール有効成分のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Paracetamol Active Pharmaceutical Ingredients will have significant change from previous year. By the most conservative estimates of global Paracetamol Active Pharmaceutical Ingredients market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Paracetamol Active Pharmaceutical Ingredients market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Paracetamol Active Pharmaceutical Ingredients...

    • ◆H&Iグローバルリサーチのお客様（例）◆